Whereas, Ehlers-Danlos Syndrome, or EDS, is an inherited condition that affects the connective tissues of the body; and
Whereas, Connective tissues provide support in skin, tendons, ligaments, blood vessels, internal organs, and bones; and
Whereas, There are 13 types of EDS caused by genetic defects in collagen, one of the major structural components of the body; and
Whereas, Symptoms of EDS may include joint hypermobility, loose, unstable joints that dislocate easily, joint pain, skin that bruises easily, digestive problems, dizziness and increased heart rate when standing up, and problems with internal organs, among others; and
Whereas, Eighty percent of people with EDS also have postural orthostatic tachycardia syndrome (POTS); and
Whereas, POTS occurs when an individual’s heart rate increases very quickly after getting up from sitting or lying down causing symptoms such as dizziness or light-headedness, fainting or almost fainting, noticeable heartbeats (heart palpitations), chest pain, shortness of breath, and shaking or sweating; and
Whereas, Those suffering from POTS may also have additional medical problems including digestion problems such as feeling or being sick, diarrhea, constipation, bloating and stomach pain, headaches and problems with sight such as blurred vision or tunnel vision, hands and feet looking purple, weakness and extreme tiredness and fatigue, and problems with thinking, memory, and concentration; and
Whereas, It is estimated that the prevalence of all types of EDS combined affect at least 1 in 5,000 people worldwide with recent research indicating that EDS is likely under diagnosed; and
Whereas, EDS may significantly decrease both quantity and quality of life for those affected; and
Whereas, Currently, there is no treatment for EDS and no known cure. Further medical research and awareness can bring hope for those with EDS; and
Whereas, Early and accurate diagnosis can help create lifesaving medical plans and improve overall quality of life; and
Whereas, A network of EDS support groups can help connect those managing life with the disease as well as better inform the health care community and the public; now, therefore, be it
Resolved by the Senate, That the members of this legislative body designate May 2025 as Ehlers-Danlos Syndrome (EDS) Awareness Month. We honor those bravely suffering from EDS and encourage scientific research and funding to find a cure.
Co-sponsored by Sens.
Adopted in the Senate by voice vote